Evidence map›Paper›PMID 30670524›Full record

ArticleBMJ open2019

Impact of palliative home care support on the quality and costs of care at the end of life: a population-level matched cohort study.

Arno Maetens, Kim Beernaert, Robrecht De Schreye, Kristof Faes, Lieven Annemans, Koen Pardon, Luc Deliens, Joachim Cohen

Abstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Application of interdisciplinary collaborative hospice care for terminal geriatric cancer patients: a prospective randomized controlled study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Differences in discharge letter content: oncologists' vs. home care physicians' needs.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arno MaetensEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) and Ghent University, Jette, Belgium.ORCID 0000-0002-4448-6036
Kim BeernaertEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) and Ghent University, Jette, Belgium.
Robrecht De SchreyeEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) and Ghent University, Jette, Belgium.
Kristof FaesEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) and Ghent University, Jette, Belgium.
Lieven AnnemansDepartment of Public Health, Interuniversity Center for Health Economic Research (ICHER), Ghent University, Gent, Belgium.
Koen PardonEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) and Ghent University, Jette, Belgium.
Luc DeliensEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) and Ghent University, Jette, Belgium.
Joachim CohenEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) and Ghent University, Jette, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the impact of palliative home care support on the quality of care and costs in the last 14 days of life.

designMatched cohort study using linked administrative databases.

settingAll people who died in Belgium in 2012 (n=107 847).

participants8837 people who received palliative home care support in the last 720 to 15 days of life matched 1:1 by propensity score to 8837 people who received usual care.

interventionReceiving the allowance for palliative home patients, multidisciplinary palliative home care team visit or palliative nurse or physiotherapist visit at home.

main outcome measuresHome death, number of family physician contacts, number of primary caregiver contacts, hospital death, hospital admission, intensive care unit (ICU) admission, emergency department (ED) admission, diagnostic testing, blood transfusion and surgery. Total inpatient and outpatient costs. All outcomes were measured in the last 14 days of life.

resultsIn the unmatched cohort, 11 149 (13.5%) people received palliative home care support in the last 720 to 15 days of life. After matching, those using palliative home care support had, compared with those who did not, more family physician contacts (mean 3.1 [SD=6.5] vs 0.8 [SD=1.2]), more chance of home death (56.2%vs13.8%; relative risk [RR]=4.08, 95% CI 3.86 to 4.31), lower risk of hospital admission (27.4%vs60.8%; RR=0.45, 95% CI 0.43 to 0.46), ICU admission (18.3%vs40.4%; RR=0.45, 95% CI 0.43 to 0.48) or ED admission (15.2%vs28.1%; RR=0.54, 95% CI 0.51 to 0.57). Mean total costs of care were lower for those using palliative home care support (€3081 [95% CI €3025 to €3136] vs €4698 [95% CI €4610 to €4787]; incremental cost: -€1617 [p<0.001]).

conclusionsPalliative home care support use positively impacts quality of care and reduces total costs of care at the end of life in Belgium. Policy makers and healthcare practitioners should increasingly focus on communicating the existing options for palliative home care support to patients and their caregivers.

Indexed as

Patient Outcome AssessmentAgedAged, 80 and overBelgiumCohort StudiesDatabases, FactualEmergency Service, HospitalFemaleHealth Care CostsHome Care ServicesHospitalizationHospital MortalityHumansIntensive Care UnitsMaleMiddle Agedhealth economicshealth Policypalliative carequality In health care

Identifiers

PMID30670524
PMCPMC6347879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.